Cargando…

Duration of Dual Antiplatelet Therapy After Stent Implantation, Still an Enigma: A Systematic Review of Randomized Clinical Trials

Dual antiplatelet therapy (DAPT) is used in patients after drug-eluting stent (DES) implantation to prevent stent thrombosis and ischemic events. The ideal duration of DAPT in patients after DES implantation is a topic of debate among clinicians. In the past, many research studies were published rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Aslam Zahid, Muhammad Bin, Memon, Marrium S, Tappiti, Mamatha, Shantha Kumar, Vignarth, Nazir, Armaan M, Koganti, Bhavya, Gupta, Kunal, Mostafa, Jihan A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671065/
https://www.ncbi.nlm.nih.gov/pubmed/34926036
http://dx.doi.org/10.7759/cureus.19549
_version_ 1784615091052740608
author Aslam Zahid, Muhammad Bin
Memon, Marrium S
Tappiti, Mamatha
Shantha Kumar, Vignarth
Nazir, Armaan M
Koganti, Bhavya
Gupta, Kunal
Mostafa, Jihan A
author_facet Aslam Zahid, Muhammad Bin
Memon, Marrium S
Tappiti, Mamatha
Shantha Kumar, Vignarth
Nazir, Armaan M
Koganti, Bhavya
Gupta, Kunal
Mostafa, Jihan A
author_sort Aslam Zahid, Muhammad Bin
collection PubMed
description Dual antiplatelet therapy (DAPT) is used in patients after drug-eluting stent (DES) implantation to prevent stent thrombosis and ischemic events. The ideal duration of DAPT in patients after DES implantation is a topic of debate among clinicians. In the past, many research studies were published related to an optimal duration of DAPT after DES implantation. In common practice, DAPT should be continued for one year or more after percutaneous coronary intervention (PCI) followed by DES implantation. The duration of DAPT is significant as long-term DAPT has beneficial effects but is associated with side effects like bleeding. On the other hand, short-term DAPT has a lower risk of bleeding, but it increases the rate of stent thrombosis or ischemic events. Our aim in this systematic review is to solve the dispute regarding the duration of DAPT after DES implantation. So, we tried to find the efficacy and safety of short-term (six months) DAPT by compiling data from randomized control trials (RCTs).  We conducted this systematic review following the guidelines defined in the preferred reporting items for systematic reviews and meta-analyses (PRISMA) checklist. We searched for our data from multiple databases like PubMed, Web of Science, ScienceDirect, and Google Scholar. We reviewed 10964 studies and then applied inclusion/exclusion criteria and PRISMA guidelines. Finally, we were left with only 21 studies regarding the optimal duration of DAPT after DES implantation. Our systematic review will help determine the non-inferiority of short-term (six months) DAPT to long-term (12 months) DAPT. Furthermore, we also noticed with short-term (six months) DAPT, there was decreased incidence of bleeding as compared to DAPT for long-term. But more studies were required to establish the safety and effectiveness of short-term (six months) DAPT compared to long-term (12 months) DAPT in patients after DES implantation. 
format Online
Article
Text
id pubmed-8671065
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-86710652021-12-16 Duration of Dual Antiplatelet Therapy After Stent Implantation, Still an Enigma: A Systematic Review of Randomized Clinical Trials Aslam Zahid, Muhammad Bin Memon, Marrium S Tappiti, Mamatha Shantha Kumar, Vignarth Nazir, Armaan M Koganti, Bhavya Gupta, Kunal Mostafa, Jihan A Cureus Cardiology Dual antiplatelet therapy (DAPT) is used in patients after drug-eluting stent (DES) implantation to prevent stent thrombosis and ischemic events. The ideal duration of DAPT in patients after DES implantation is a topic of debate among clinicians. In the past, many research studies were published related to an optimal duration of DAPT after DES implantation. In common practice, DAPT should be continued for one year or more after percutaneous coronary intervention (PCI) followed by DES implantation. The duration of DAPT is significant as long-term DAPT has beneficial effects but is associated with side effects like bleeding. On the other hand, short-term DAPT has a lower risk of bleeding, but it increases the rate of stent thrombosis or ischemic events. Our aim in this systematic review is to solve the dispute regarding the duration of DAPT after DES implantation. So, we tried to find the efficacy and safety of short-term (six months) DAPT by compiling data from randomized control trials (RCTs).  We conducted this systematic review following the guidelines defined in the preferred reporting items for systematic reviews and meta-analyses (PRISMA) checklist. We searched for our data from multiple databases like PubMed, Web of Science, ScienceDirect, and Google Scholar. We reviewed 10964 studies and then applied inclusion/exclusion criteria and PRISMA guidelines. Finally, we were left with only 21 studies regarding the optimal duration of DAPT after DES implantation. Our systematic review will help determine the non-inferiority of short-term (six months) DAPT to long-term (12 months) DAPT. Furthermore, we also noticed with short-term (six months) DAPT, there was decreased incidence of bleeding as compared to DAPT for long-term. But more studies were required to establish the safety and effectiveness of short-term (six months) DAPT compared to long-term (12 months) DAPT in patients after DES implantation.  Cureus 2021-11-13 /pmc/articles/PMC8671065/ /pubmed/34926036 http://dx.doi.org/10.7759/cureus.19549 Text en Copyright © 2021, Aslam Zahid et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiology
Aslam Zahid, Muhammad Bin
Memon, Marrium S
Tappiti, Mamatha
Shantha Kumar, Vignarth
Nazir, Armaan M
Koganti, Bhavya
Gupta, Kunal
Mostafa, Jihan A
Duration of Dual Antiplatelet Therapy After Stent Implantation, Still an Enigma: A Systematic Review of Randomized Clinical Trials
title Duration of Dual Antiplatelet Therapy After Stent Implantation, Still an Enigma: A Systematic Review of Randomized Clinical Trials
title_full Duration of Dual Antiplatelet Therapy After Stent Implantation, Still an Enigma: A Systematic Review of Randomized Clinical Trials
title_fullStr Duration of Dual Antiplatelet Therapy After Stent Implantation, Still an Enigma: A Systematic Review of Randomized Clinical Trials
title_full_unstemmed Duration of Dual Antiplatelet Therapy After Stent Implantation, Still an Enigma: A Systematic Review of Randomized Clinical Trials
title_short Duration of Dual Antiplatelet Therapy After Stent Implantation, Still an Enigma: A Systematic Review of Randomized Clinical Trials
title_sort duration of dual antiplatelet therapy after stent implantation, still an enigma: a systematic review of randomized clinical trials
topic Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671065/
https://www.ncbi.nlm.nih.gov/pubmed/34926036
http://dx.doi.org/10.7759/cureus.19549
work_keys_str_mv AT aslamzahidmuhammadbin durationofdualantiplatelettherapyafterstentimplantationstillanenigmaasystematicreviewofrandomizedclinicaltrials
AT memonmarriums durationofdualantiplatelettherapyafterstentimplantationstillanenigmaasystematicreviewofrandomizedclinicaltrials
AT tappitimamatha durationofdualantiplatelettherapyafterstentimplantationstillanenigmaasystematicreviewofrandomizedclinicaltrials
AT shanthakumarvignarth durationofdualantiplatelettherapyafterstentimplantationstillanenigmaasystematicreviewofrandomizedclinicaltrials
AT nazirarmaanm durationofdualantiplatelettherapyafterstentimplantationstillanenigmaasystematicreviewofrandomizedclinicaltrials
AT kogantibhavya durationofdualantiplatelettherapyafterstentimplantationstillanenigmaasystematicreviewofrandomizedclinicaltrials
AT guptakunal durationofdualantiplatelettherapyafterstentimplantationstillanenigmaasystematicreviewofrandomizedclinicaltrials
AT mostafajihana durationofdualantiplatelettherapyafterstentimplantationstillanenigmaasystematicreviewofrandomizedclinicaltrials